AGGF1P5

Across TCGA pan-cancer cohorts, AGGF1P5 RNA is linked to patient survival in 14 of 34 cancer types, making it the most broadly survival-associated AGGF1P5 data layer.

The strongest signal is observed in testicular germ cell tumors (TGCT), where higher AGGF1P5 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated AGGF1P5 expression acts as an unfavorable survival marker, although some lineages such as SKCM and LUSC show a favorable association.

TGCT, KIRC, and BLCA are the cancer types where AGGF1P5 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
TGCT	DFS	Tertile	II,III,IV	0.015	0.919	<.001	54	view →
KIRC	DFS	Tertile	III,IV	0.441	0.652	.018	42	view →
BLCA	DFS	Tertile	All	0.078	0.594	<.001	27	view →
THYM	DFS	Tertile	III,IV	0.205	0.774	.007	18	view →
SKCM	DFS	Tertile	II,III,IV	1.000	0.681	.026	18	view →
GBM	OS	Tertile	All	0.253	0.431	.003	18	view →
ESCA	OS	Tertile	All	0.211	0.876	.028	18	view →
COAD	DFS	Tertile	II,III,IV	0.054	0.756	<.001	18	view →
LUAD	DFS	Tertile	All	0.301	0.679	.024	18	view →
UCEC	DFS	Tertile	All	0.408	0.650	.034	12	view →
STAD	DFS	Tertile	IV	0.098	0.479	.048	9	view →
SARC	DFS	Tertile	All	0.188	0.594	.043	9	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 14 lineages.

AGGF1P5–TGCT (DFS)

Open the TGCT breakdown →